公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2019 | Decreased Colorectal Adenoma Risk after Helicobacter pylori Eradication: A Retrospective Cohort Study | Hu K.-C.; MING-SHIANG WU ; Chu C.-H.; Wang H.-Y.; Lin S.-C.; Liu C.-C.; TUNG-HUNG SU ; WEI-CHIH LIAO ; CHI-LING CHEN ; CHUN-JEN LIU ; Shih S.-C. | Clinical Infectious Diseases | 15 | 14 | |
2019 | Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers | KAI-CHI CHANG ; MEI-HWEI CHANG ; CHIEN-NAN LEE ; Chang C.-H.; JIA-FENG WU ; YEN-HSUAN NI ; Wen W.-H.; MING-KWANG SHYU ; Lai M.-W.; Chen S.-M.; Hu J.-J.; Lin H.H.; Hsu J.-J.; Mu S.-C.; Lin Y.-C.; CHUN-JEN LIU ; DING-SHINN CHEN ; Lin L.-H.; HUEY-LING CHEN ; HSIAO-LIN HWA ; Su Y.-N.; JIN-CHUNG SHIH ; KUANG-HAN CHAO ; HONG-YUAN HSU ; YU-CHUN CHIU ; TUNG-HUNG SU ; Lin C.-C.; Lin P.-Y.; Yang W.-R.; Zhao L.-L.; Yang C.-K.; Chang Y.-K.; Chen K.-H.; Lin Y.-H.; Chen H.-J.; Pan H.-S.; Lau B.-H.; Lee C.-L.; Cheng P.-J.; Chang Y.-L.; Chiueh H.-Y.; Wang T.-H.; Lo L.-M.; Hsieh C.-L.; Cheng S.-W.; Tsai M.-S.; She B.-Q.; Koh K.-J.; Hung Y.-L.; Lin H.-M.; Peng F.-S.; Wu T.-C.; Chen C.-Y.; Chen C.-P.; Huang J.-P.; Yeung C.-Y.; Lin C.-J.; Chiu W.-T.; Wang D.-S.; Lin W.-T.; Hwang K.-S.; Huang C.-F.; The Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT study) | Alimentary Pharmacology and Therapeutics | 19 | 18 | |
2012 | Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load | TAI-CHUNG TSENG ; CHUN-JEN LIU ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; CHI-LING CHEN ; Fang-Tzu Kuo S; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology | 129 | 115 | |
2023 | Differential Relapse Patterns After Discontinuation of Entecavir vs Tenofovir Disoproxil Fumarate in Chronic Hepatitis B | Choi, Hannah S J; Hirode, Grishma; Chen, Chien-Hung; TUNG-HUNG SU ; Seto, Wai-Kay; Van Hees, Stijn; Papatheodoridi, Margarita; Lens, Sabela; Wong, Grace L H; Brakenhoff, Sylvia M; Chien, Rong-Nan; Feld, Jordan J; Sonneveld, Milan J; Chan, Henry L Y; Forns, Xavier; Papatheodoridis, George V; Vanwolleghem, Thomas; Yuen, Man-Fung; Hsu, Yao-Chun; JIA-HORNG KAO ; Cornberg, Markus; Hansen, Bettina E; Jeng, Wen-Juei; Janssen, Harry L A | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 9 | | |
2023 | Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B | SHANG-CHIN HUANG ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; CHI-LING CHEN ; SHIH-JER HSU ; SIH-HAN LIAO ; CHUN-MING HONG ; CHEN-HUA LIU ; Lan, Ting-Yuan; HUNG-CHIH YANG ; CHUN-JEN LIU ; PEI-JER CHEN ; JIA-HORNG KAO | Hepatology international | 5 | 2 | |
2013 | Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion | HUNG-CHIH YANG ; CHI-LING CHEN ; Shen Y.-C; Peng C.-Y; CHUN-JEN LIU ; TAI-CHUNG TSENG ; TUNG-HUNG SU ; Chuang W.-L; Yu M.-L; Dai C.-Y; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology | 43 | 37 | |
2018 | Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir Therapy | TUNG-HUNG SU ; HUNG-CHIH YANG ; TAI-CHUNG TSENG ; JYH-MING LIOU ; CHEN-HUA LIU ; CHI-LING CHEN ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU ; JIA-HORNG KAO | Journal of Infectious Diseases | 57 | 52 | |
2023 | Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease | Lin, Meng-Ju; TUNG-HUNG SU ; CHIEH-CHANG CHEN ; WEI-KAI WU ; SHIH-JER HSU ; TAI-CHUNG TSENG ; SIH-HAN LIAO ; CHUN-MING HONG ; HUNG-CHIH YANG ; CHUN-JEN LIU ; MING-SHIANG WU ; JIA-HORNG KAO | Gut pathogens | 2 | 2 | |
2019 | Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection | TUNG-HUNG SU ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; SHANG-JU WU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 10 | 9 | |
2023 | Effects of transjugular intrahepatic portosystemic shunt on abdominal muscle mass in patients with decompensated cirrhosis | CHIH-HORNG WU ; MING-CHIH HO ; JIA-HORNG KAO ; CHENG-MAW HO ; TUNG-HUNG SU ; SHIH-JER HSU ; Huang, Hsiang-Yun; Lin, Chun-Yu; PO-CHIN LIANG | Journal of the Formosan Medical Association = Taiwan yi zhi | 3 | 0 | |
2016 | Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan | Wang C.-C.; Lin C.-L.; Hsieh T.-Y.; Tseng K.-C.; Peng C.-Y.; TUNG-HUNG SU ; Yang S.-S.; Hsu Y.-C.; Chen T.-M.; JIA-HORNG KAO | Hepatology International | 3 | 3 | |
2016 | Efficacy of entecavir therapy for hepatitis B e-antigen positive chronic hepatitis B patients with prior exposure to interferon or nucleoside/nucleotide analogues | Tseng K.-C.; Tseng C.-W.; Hsieh T.-Y.; Peng C.-Y.; Lin C.-L.; TUNG-HUNG SU ; TAI-CHUNG TSENG ; Lin H.H.; Wang C.-C.; JIA-HORNG KAO | Hepatology Research | 2 | 0 | |
2015 | Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus | HUEY-LING CHEN ; CHIEN-NAN LEE ; Chang C.-H.; YEN-HSUAN NI ; MING-KWANG SHYU ; Chen S.-M.; Hu J.-J.; Lin H.H.; Zhao L.-L.; Mu S.-C.; Lai M.-W.; Lee C.-L.; Lin H.-M.; Tsai M.-S.; Hsu J.-J.; DING-SHINN CHEN ; KIN-WEI CHAN ; MEI-HWEI CHANG ; Su Y.-N.; JIN-CHUNG SHIH ; KUANG-HAN CHAO ; JIA-FENG WU ; HONG-YUAN HSU ; CHUN-JEN LIU ; TUNG-HUNG SU ; Lin C.-C.; Lin P.-Y.; Yang W.-R.; Yang C.-K.; Chang Y.-K.; Chen K.-H.; Lin Y.-H.; Chen H.-J.; Pan H.-S.; Lau B.-H.; Cheng P.-J.; Chang Y.-L.; Chiueh H.-Y.; Wang T.-H.; Lo L.-M.; Hsieh C.-L.; Cheng S.-W.; Lin L.-H.; She B.-Q.; Koh K.-J.; Hung Y.-L.; Peng F.-S.; Lin Y.-C.; Wu T.-C.; Chen C.-Y.; Chen C.-P.; Huang J.-P.; Yeung C.-Y.; Lin C.-J.; Chiu W.-T.; Wang D.-S.; Lin W.-T.; Hwang K.-S.; Huang C.-F.; Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT Study) | Hepatology | 216 | 187 | |
2020 | Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis | CHEN-HUA LIU ; Peng C.-Y.; YU-JEN FANG ; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; TUNG-HUNG SU ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Scientific Reports | 8 | 6 | |
2012 | Emerging hepatitis B virus infection in vaccinated populations: A rising concern? | TUNG-HUNG SU ; PEI-JER CHEN | Emerging Microbes and Infections | 13 | 10 | |
2020 | Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antivirals | CHEN-HUA LIU ; Lee M.-H.; JOU-WEI LIN ; CHUN-JEN LIU ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Hepatology | 41 | 43 | |
2021 | Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus-coinfected patients receiving sofosbuvir-based direct-acting antivirals and antiretroviral therapy | CHEN-HUA LIU ; HSIN-YUN SUN ; SZU-MIN HSIEH ; Liu W.-C.; WANG-HUEI SHENG ; CHUN-JEN LIU ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; PEI-JER CHEN ; CHIEN-CHING HUNG ; JIA-HORNG KAO | Journal of Viral Hepatitis | 6 | 6 | |
2017 | Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular Carcinoma | TAI-CHUNG TSENG ; CHUN-JEN LIU ; TUNG-HUNG SU ; Yang W.-T; CHI-LING CHEN ; HUNG-CHIH YANG ; Wang C.-C; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | American Journal of Gastroenterology | 42 | 39 | |
2018 | Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection | TAI-CHUNG TSENG ; CHUN-JEN LIU ; TUNG-HUNG SU ; Yang W.-T; CHI-LING CHEN ; HUNG-CHIH YANG ; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 18 | 18 | |
2016 | Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients | TUNG-HUNG SU ; Hu T.-H.; Chen C.-Y.; Huang Y.-H.; Chuang W.-L.; Lin C.-C.; Wang C.-C.; Su W.-W.; Chen M.-Y.; Peng C.-Y.; Chien R.-N.; Huang Y.-W.; Wang H.-Y.; Lin C.-L.; Yang S.-S.; Chen T.-M.; Mo L.-R.; SHIH-JER HSU ; Tseng K.-C.; Hsieh T.-Y.; Suk F.-M.; Hu C.-T.; Bair M.-J.; Liang C.-C.; Lei Y.-C.; TAI-CHUNG TSENG ; CHI-LING CHEN ; JIA-HORNG KAO ; the C-TEAM study group; the Taiwan Liver Diseases Consortium | Liver International | 165 | 149 | |